MedTrace Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $19.7M

  • Investors
  • 14

MedTrace General Information

Description

Developer of medical devices designed to offer novel safety features to revolutionize blood flow imaging in PET. The company's platform offers an automated on-site production and infusion system for water in the scanner suite to innovate diagnostic imaging by transforming blood flow quantification, enabling physicians to get a platform that assists in focusing on heart-study applications, and brain and tumor vascularization.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Agern Allé 5A
  • 2970 Hørsholm
  • Denmark
+45 31
Primary Industry
Diagnostic Equipment
Corporate Office
  • Agern Allé 5A
  • 2970 Hørsholm
  • Denmark
+45 31

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MedTrace Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series C) 21-Sep-2023 $19.7M Completed Clinical Trials - Phase 3
11. Later Stage VC 24-May-2022 Completed Clinical Trials - Phase 3
10. Later Stage VC (Series B) 11-May-2021 Completed Clinical Trials - Phase 3
9. Later Stage VC 08-Apr-2020 Completed Clinical Trials - Phase 3
8. Grant 01-Mar-2020 Completed Startup
7. Early Stage VC 03-Jul-2019 Completed Pre-Clinical Trials
6. Angel (individual) 10-Mar-2017 Completed Startup
5. Accelerator/Incubator 01-Jan-2016 Completed Pre-Clinical Trials
4. Grant 14-Dec-2015 $389K Completed Pre-Clinical Trials
3. Early Stage VC 01-Sep-2015 Completed Pre-Clinical Trials
To view MedTrace’s complete valuation and funding history, request access »

MedTrace Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 187,944 $7.68 $7.68 1x $7.68 4.14%
Ordinary 125,489 $6.14 $6.14 1x $6.14 2.76%
To view MedTrace’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MedTrace Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to offer novel safety features to revolutionize blood flow imaging in PET. The com
Diagnostic Equipment
Hørsholm, Denmark
44 As of 2026

Lansing, MI
 

Mountain View, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MedTrace Competitors (3)

One of MedTrace’s 3 competitors is Ionetix, a Formerly VC-backed company based in Lansing, MI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ionetix Formerly VC-backed Lansing, MI
HeartFlow Formerly VC-backed Mountain View, CA
Blue Earth Therapeutics Venture Capital-Backed Oxford, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

MedTrace Patents

MedTrace Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018115286-A1 An infusion system for short-lived radiopharmaceuticals Inactive 21-Dec-2016
US-20200085977-A1 Diagnostic usages of short-lived radiopharmaceuticals Active 21-Dec-2016
WO-2018115299-A1 Diagnostic usages of short-lived radiopharmaceuticals Inactive 21-Dec-2016
JP-2020514265-A Diagnostic use of short-lived radiopharmaceuticals Active 21-Dec-2016
JP-2020501827-A Infusion system for short-lived radiopharmaceuticals Active 21-Dec-2016 A61M5/007
To view MedTrace’s complete patent history, request access »

MedTrace Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedTrace Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTravest Venture Capital Minority
Oceanventures Venture Capital Minority
BankInvest Group Asset Manager Minority
Swisscanto Holding Asset Manager Minority
The ATP Group Limited Partner Minority
You’re viewing 5 of 14 investors. Get the full list »

MedTrace Acquisitions (1)

MedTrace’s most recent deal was a Merger/Acquisition with aQuant (Outcome Management (Healthcare)). The deal was made on 01-Jan-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
aQuant (Outcome Management (Healthcare)) 01-Jan-2018 Merger/Acquisition Outcome Management (Healthcare)
To view MedTrace’s complete acquisitions history, request access »

MedTrace FAQs

  • When was MedTrace founded?

    MedTrace was founded in 2015.

  • Where is MedTrace headquartered?

    MedTrace is headquartered in Hørsholm, Denmark.

  • What is the size of MedTrace?

    MedTrace has 44 total employees.

  • What industry is MedTrace in?

    MedTrace’s primary industry is Diagnostic Equipment.

  • Is MedTrace a private or public company?

    MedTrace is a Private company.

  • What is the current valuation of MedTrace?

    The current valuation of MedTrace is .

  • What is MedTrace’s current revenue?

    The current revenue for MedTrace is .

  • How much funding has MedTrace raised over time?

    MedTrace has raised $71.2M.

  • Who are MedTrace’s investors?

    MedTravest, Oceanventures, BankInvest Group, Swisscanto Holding, and The ATP Group are 5 of 14 investors who have invested in MedTrace.

  • Who are MedTrace’s competitors?

    Ionetix, HeartFlow, and Blue Earth Therapeutics are competitors of MedTrace.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process